Brief: Incannex Announces IHL-216A Observed To Have A Neuroprotective Effect In A Rodent Model Of Sports Concussion Rapidly Restores Spatial Memory Post-Concussion
10/05/2022 13:07
May 10 (Reuters) - Incannex Healthcare Ltd IHL.AX :
* INCANNEX ANNOUNCES IHL-216A OBSERVED TO HAVE A
NEUROPROTECTIVE
EFFECT IN A RODENT MODEL OF SPORTS CONCUSSION; RAPIDLY RESTORES
SPATIAL MEMORY POST-CONCUSSION
* INCANNEX HEALTHCARE LTD - NOW TARGETS A PRE-IND MEETING
WITH
U.S. FDA IN Q3 2022 TO DISCUSS AN EXPEDITED CLINICAL TRIAL
PROGRAM
Source text for Eikon: ID:nPn55NHNca
Further company coverage: IHL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsBrief: Incannex Healthcare Says Computershare To Be Appointed As US Transfer Agent
Brief: Incannex Healthcare Says Federal Court Of Australia Approved Proposed Schemes Of Arrangement Between Incannex And Its Shareholders
Australia's Incannex up as shareholders in favour of US redomicile
Brief: Incannex Healthcare Will Prepare FDA Ind Application PSI-Gad
Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed